J. Steven Leeder

1. Cytochrome P450 3A
   1999/01/01 by Saskia N. de Wildt, Gregory L. Kearns, J Steven Leeder +3 · 7 citations
   Pharmacology, Toxicology and Pharmaceutics · Medicine · #Pharmacogenetics and Drug Metabolism #Drug-Induced Hepatotoxicity and Protection #Drug Transport and Resistance Mechanisms
2. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants
   2023/04/10 by Chad A. Bousman, Chad Bousman, James M. Stevenson +18 · 28 citations
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Diet and metabolism studies #Pharmacogenetics and Drug Metabolism #Treatment of Major Depression
3. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy
   2021/01/02 by Kristine R. Crews, Andrew A. Monte, Rachel Huddart +18 · 3 citations
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Diet and metabolism studies #Pharmaceutical studies and practices #Pharmacogenetics and Drug Metabolism
4. Clinical Implications of Altered Drug Transporter Abundance/Function and PBPK Modeling in Specific Populations: An ITC Perspective
   2022/05/13 by Xiaoyan Chu, Bhagwat Prasad, Sibylle Neuhoff +8 · 1 voice · 1 citation
   Medicine · Pharmacology, Toxicology and Pharmaceutics · #Drug Transport and Resistance Mechanisms #Pharmacogenetics and Drug Metabolism #Pharmacological Effects and Toxicity Studies